Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $141,146.64 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis sold 376 shares of the firm’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $375.39, for a total value of $141,146.64. Following the transaction, the executive vice president now directly owns 5,507 shares of the company’s stock, valued at approximately $2,067,272.73. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Robert Desantis also recently made the following trade(s):

• On Friday, April 26th, Robert Desantis sold 1,498 shares of Intuitive Surgical stock. The stock was sold at an average price of $369.92, for a total transaction of $554,140.16.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.16, for a total value of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.80, for a total value of $7,992,564.80.

Intuitive Surgical Stock Performance

ISRG stock traded down $3.52 during midday trading on Tuesday, reaching $370.62. The company’s stock had a trading volume of 1,204,415 shares, compared to its average volume of 1,637,873. The stock has a fifty day simple moving average of $386.10 and a two-hundred day simple moving average of $347.50. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The firm has a market capitalization of $131.46 billion, a price-to-earnings ratio of 67.53, a PEG ratio of 4.85 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the firm posted $1.00 earnings per share. The business’s revenue was up 11.5% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on the company. Robert W. Baird lowered their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. Wells Fargo & Company increased their target price on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Royal Bank of Canada increased their target price on Intuitive Surgical from $400.00 to $432.00 and gave the company an “outperform” rating in a research report on Wednesday, January 24th. Raymond James increased their target price on Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research report on Thursday, January 25th. Finally, Jefferies Financial Group increased their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Five investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average price target of $396.17.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Baystate Wealth Management LLC raised its position in Intuitive Surgical by 150.0% during the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 45 shares in the last quarter. MCF Advisors LLC increased its position in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares in the last quarter. Able Wealth Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Atticus Wealth Management LLC increased its position in shares of Intuitive Surgical by 85.4% in the fourth quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider’s stock valued at $30,000 after buying an additional 41 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.